Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence

Volume: 14, Issue: 3, Pages: 252 - 261
Published: Aug 30, 2021
Abstract
Other SectionsAbstractIntroduction to COVID-19 and TreatmentsCytokine Storm in COVID-19The Role of Exosomes in the Management of Cytokine StormThe Diverse Sources of MSC-Derived Exosomes as Therapeutic Approach for COVIDPreclinical Studies on MSC-Derived Exosome for COVID-19 TreatmentClinical Trials on MSC-Derived Exosome for COVID-19 Treatment and Their LimitationsConclusionsAcknowledgmentsPotential Conflict of...
Paper Details
Title
Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence
Published Date
Aug 30, 2021
Volume
14
Issue
3
Pages
252 - 261
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.